Perform Another (Advanced) Search

1.  Study Posting (1918) Trial #159183, Breast Cancer, Savannah, GA
...1918) Trial #159183, Breast Cancer, Savannah, GA Trial Information Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer CTSU/IBCSG 24-02 RATIONALE ...
View Page

2.  Study Posting (1819) Trial #87341, Desmoid Tumors, Cincinnati, OH
...Trial #87341, Desmoid Tumors, Cincinnati, OH Trial Information A Phase II Study of Sulindac and Tamoxifen in Patients with Desmoid Tumors that are Recurrent or Not Amenable to Standard Therapy What ...
...published reports suggest that sulindac may have anti-tumor activity in adults with desmoid tumor. Tamoxifen is an estrogen-blocking drug approved for the treatment of breast cancer. Researchers have also ...
View Page

3.  Study Posting (1819) Trial #83942, Solid Tumors, Cincinnati, OH
...Trial #83942, Solid Tumors, Cincinnati, OH Trial Information A Phase II Study of Sulindac and Tamoxifen in Patients with Desmoid Tumors that are Recurrent or Not Amenable to Standard Therapy What ...
...published reports suggest that sulindac may have anti-tumor activity in adults with desmoid tumor. Tamoxifen is an estrogen-blocking drug approved for the treatment of breast cancer. Researchers have also ...
View Page

4.  Study Posting (2332) Trial #37434, Breast Cancer, Jamaica, NY
...Study Posting (2332) Trial #37434, Breast Cancer, Jamaica, NY Trial Information Study of Tamoxifen and Raloxifene for the Prevention of Breast Cancer (STAR) The Queens Cancer Center of Queens ...
...Breast and Bowel Project) is currently conducting STAR. Recently, clinical research studies have shown that Tamoxifen will actually prevent breast cancer in many women. Raloxifene, a medication similar to Tamoxifen has ...
View Page

5.  Study Posting (2332) Trial #37433, Post Menopause, Jamaica, NY
...Study Posting (2332) Trial #37433, Post Menopause, Jamaica, NY Trial Information Study of Tamoxifen and Raloxifene for the Prevention of Breast Cancer (STAR) The Queens Cancer Center of Queens ...
...Breast and Bowel Project) is currently conducting STAR. Recently, clinical research studies have shown that Tamoxifen will actually prevent breast cancer in many women. Raloxifene, a medication similar to Tamoxifen has ...
View Page

6.  Study Posting (1918) Trial #158890, Endometrial Cancer, Savannah, GA
...1918) Trial #158890, Endometrial Cancer, Savannah, GA Trial Information Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer RATIONALE : Temsirolimus may stop the ...
...growth. Estrogen can cause the growth of endometrial cancer cells. Hormone therapy using megestrol and tamoxifen may fight endometrial cancer by blocking the use of estrogen by the tumor cells. It ...
View Page

7.  Study Posting (2348) Trial #87098, Ovarian Cancer, New York, NY
...Posting (2348) Trial #87098, Ovarian Cancer, New York, NY Trial Information A Randomized Study of Tamoxifen Versus Thalidomide (NSC# 66847) in Patients with Biochemical-Recurrence-Only-Epithelial Ovarian Cancer, Cancer of ...
...The purpose of this study is to determine which of the following drugs, thalidomide or tamoxifen, may help to prevent the cancer from returning for the longest period of time. In ...
View Page

8.  Study Posting (2246) Trial #48029, Spinal Cord Malignancy, Duarte, CA
...Posting (2246) Trial #48029, Spinal Cord Malignancy, Duarte, CA Trial Information A Pilot Study of Tamoxifen, Carboplatin and Topotecan in the Treatment of Recurrent or Refractory Primary Brain or Spinal Cord ...
...nervous system. The purpose of this research is study the effect of the combination of Tamoxifen, Topotecan and Carboplatin this type of cancer. Your treatment on this study is expected to ...
View Page

9.  Study Posting (4694) Trial #150196, Breast Cancer, Poughkeepsie, NY
...in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor ...
...that was considered to be borderline for hormone receptor positivity and who were treated with tamoxifen and/or an AI are eligible for this study). • Patients must have undergone either a ...
View Page

10.  Study Posting (1918) Trial #158900, Endometrial Cancer, Savannah, GA
...1918) Trial #158900, Endometrial Cancer, Savannah, GA Trial Information Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer To estimate the antitumor activity ...
...University Medical Center support@centerwatch.com sharppa1@memorialhealth.com Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer Endometrial Cancer Savannah, GA 158900 ...
View Page

11.  Study Posting (4694) Trial #150197, Women's Health, Poughkeepsie, NY
...in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor ...
...that was considered to be borderline for hormone receptor positivity and who were treated with tamoxifen and/or an AI are eligible for this study). • Patients must have undergone either a ...
View Page

12.  CenterWatch: Clinical Trials in Category (246) Spinal Cord Malignancy
...Spinal Cord Malignancy State • California • Ohio California Duarte : City of Hope A Pilot Study of Tamoxifen, Carboplatin and Topotecan in the Treatment of Recurrent or Refractory Primary Brain or Spinal Cord ...
View Page

13.  Newly Approved Drug Therapies (775) Faslodex (fulvestrant), AstraZeneca,
...use in postmenopausal women whose disease has progressed after receiving anti-estrogen therapy (such as tamoxifen). The therapy is given as a once-a-month intramuscular injection. After breast cancer diagnosis ...
...found to be estrogen receptor positive, treatment options include an anti-estrogen therapy such as tamoxifen, which blocks the estrogen receptor. Faslodex may be an effective alternative for patients who are ...
View Page

14.  Study Posting (797) Trial #140872, Breast Cancer, Elgin, IL
...in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor ...
...in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor ...
View Page

15.  Study Posting (2246) Trial #109597, Breast Cancer, Duarte, CA
...in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (A1) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor ...
...in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (A1) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor ...
View Page

16.  CenterWatch: New Medical Therapies in Disease Category (29), Breast Cancer
...the subjects were randomized to one of four study groups: anastrozole plus Zometa; anastrozole alone; tamoxifen plus Zometa or tamoxifen alone. The treatment duration was three years. The primary endpoint was disease-free survival and ...
View Page

17.  Newly Approved Drug Therapies (587) Aromasin Tablets, Pharmacia & Upjohn,
...Treatment Area: Treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy General Information Aromasin, a new drug to treat post-menopausal advanced breast cancer in ...
View Page

18.  Newly Approved Drug Therapies (698) Femara (letrozole), Novartis,
...a randomized, double-blind, multinational phase III trial that compared Femara 2.5 mg to tamoxifen 20 mg in 907 postmenopausal women with locally advanced (stage IIIB) disease, metastatic breast cancer ...
...progression of advanced breast cancer for 9.4 months compared to 6.0 months for tamoxifen. Significant differences were also observed between Femara and tamoxifen in terms of objective response rate ...
View Page

19.  CenterWatch: New Medical Therapies in Disease Category (274), Post Menopause
...letrozole) improves survival of postmenopausal women with locally advanced or metastatic breast cancer compared to tamoxifen. The randomized, double-blind trial consisted of 907 postmenopausal women, with 453 receiving Femara and 454 receiving tamoxifen. At one and two years, data demonstrated that Femara produced a statistically significant survival advantage ...
View Page

20.  Study Posting (1918) Trial #161384, Breast Cancer, Savannah, GA
...with 1 of the following: • Aromatase inhibitor* (AI) • Combination of up to 3 years of tamoxifen citrate followed by an AI for a total of 5 years • No tamoxifen citrate during years 4 and 5 of 5-year adjuvant hormonal therapy NOTE: *Adjuvant AI ...
View Page